Nitroglycerin disposition in human blood
- PMID: 3935462
- DOI: 10.1007/BF00547417
Nitroglycerin disposition in human blood
Abstract
The disposition in vitro of nitroglycerin (GTN) and its metabolites in erythrocyte suspensions, plasma and blood has been studied using labelled (3H) and unlabelled GTN and GTN metabolites separated by HPLC. GTN was rapidly metabolised (t1/2 3 min) to dinitro-metabolites and subsequently to the mononitronitrates in erythrocyte suspensions containing a therapeutic concentration of GTN (0.8-10 ng/ml). The metabolism of GTN and its dinitro-metabolites was concentration dependent. GTN and its dinitro-metabolites were plasma protein bound (11-60%). They had an apparent erythrocyte-plasma partition coefficient in the range 0.6 to 0.9. The metabolism of GTN by erythrocytes was partially inhibited by the presence of the dinitro-metabolites of GTN. The metabolism of GTN in blood samples collected from patients could be stopped by adding the collected blood to chilled tubes containing the enzyme inhibitor iodoacetamide.
Similar articles
-
Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.Clin Pharmacokinet. 2003;42(3):205-21. doi: 10.2165/00003088-200342030-00001. Clin Pharmacokinet. 2003. PMID: 12603173 Review.
-
Rapid disappearance of nitroglycerin following incubation with human blood.Can J Physiol Pharmacol. 1980 May;58(5):459-62. doi: 10.1139/y80-077. Can J Physiol Pharmacol. 1980. PMID: 6774803
-
Biotransformation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin.Can J Physiol Pharmacol. 1984 Jun;62(6):704-6. doi: 10.1139/y84-116. Can J Physiol Pharmacol. 1984. PMID: 6430533
-
Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.Arzneimittelforschung. 1994 Aug;44(8):951-3. Arzneimittelforschung. 1994. PMID: 7945539 Clinical Trial.
-
Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase.Trends Cardiovasc Med. 2006 Nov;16(8):259-65. doi: 10.1016/j.tcm.2006.05.001. Trends Cardiovasc Med. 2006. PMID: 17055381 Review.
Cited by
-
Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.Br J Clin Pharmacol. 1987 Mar;23(3):287-93. doi: 10.1111/j.1365-2125.1987.tb03047.x. Br J Clin Pharmacol. 1987. PMID: 3105569 Free PMC article.
-
Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.Clin Pharmacokinet. 1987 Jan;12(1):1-11. doi: 10.2165/00003088-198712010-00001. Clin Pharmacokinet. 1987. PMID: 3102143 Review.
-
A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats.Pharm Res. 1994 Aug;11(8):1190-8. doi: 10.1023/a:1018953319288. Pharm Res. 1994. PMID: 7971723
-
Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.J Pharmacokinet Biopharm. 1993 Oct;21(5):533-50. doi: 10.1007/BF01059113. J Pharmacokinet Biopharm. 1993. PMID: 8145130
-
Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.Clin Pharmacokinet. 2003;42(3):205-21. doi: 10.2165/00003088-200342030-00001. Clin Pharmacokinet. 2003. PMID: 12603173 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources